VANCOUVER—The incidence, prevalence and mortality associated with colorectal cancer all declined in the United States from 1990 to 2019, but…
Browsing: Clinical Updates
In this month’s column, I highlight three topics that are highly relevant to endoscopy clinical practice: colon polyp sizing, Helicobacter…
Mainz Biomed N.V., a molecular genetics diagnostic company specializing in early cancer detection, has unveiled the significant findings of its…
Skyrizi (Risankizumab) demonstrated its non-inferiority to Stelara in achieving clinical remission at 24 weeks and its superiority in endoscopic remission…
Olympus Corporation, a leading global medical technology company, has announced the market launch of its next-generation EVIS X1™ endoscopy system.…
CHICAGO—On average, surgeons are much less likely than gastroenterologists to detect adenomas during routine screening colonoscopy, according to a VA…
The Association for Molecular Pathology (AMP), in collaboration with the American Society of Clinical Oncology (ASCO) and the College of…
Medical-device company Invenio Imaging is at the forefront of a technological breakthrough. They are developing a system that allows surgeons…
Dr. Aasma Shaukat, a gastroenterologist and researcher in colon cancer screening, discusses the conflicting colorectal cancer (CRC) screening recommendations. The…
Patients with confirmed nonerosive gastroesophageal reflux disease (GERD) are not at greater risk for esophageal cancer compared with the general…